SGT-53

· SynerGene Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SGT-53, covering 2017-04-26 to 2025-05-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors [Phase 1]